-
Join 34 other subscribers
Categories
Top Posts
Blogroll
Author Archives: Alexander Szewczak
Consolidation in the Pharma industry continues unabated
As large assets swaps, mergers and acquisitions continue in the Pharma industry, Merck has announced it is selling its Consumer Care division to Bayer for $14B. The transaction will move Bayer into second place in consumer care, behind J&J. Merck … Continue reading
Posted in Pharmaceutical Industry
Tagged asset sales, Bayer, Merck, Pharmaceutical industry
Leave a comment
Pfizer won’t take no for an answer
Amidst several indications that Pfizer will launch a hostile bid for AstraZeneca if necessary, this quote stands out: Asked whether hostile moves could hurt integration of the two companies, Chief Executive Ian Read said, “No, in my opinion, all it … Continue reading
Posted in Pharmaceutical Industry
Tagged AstraZeneca, hostile takeover, Ian Read, merger, Pfizer
Leave a comment
Pharma companies consider selling off mature drug portfolios
As big shifts in the Pharmaceutical industry continue, Reuters is reporting that several large pharma companies, including Abbott, Merck and Sanofi, are considering selling off their portfolios of compounds that have lost patent protection. From a pharma company’s perspective, branded … Continue reading
Tidal Basin, Washington DC
Alas, I arrived after the cherry blossoms, but the professionals caught some spectacular images a few weeks earlier. And check out this humorous — and beautiful — look at the blossom paparazzi!
Not just Microsoft: All companies need a data culture
What Microsoft needs is a “data culture”, according to Satya Nadella, their new CEO and former head of the Cloud and Enterprise group. As reported by Adam Lashinsky: In Nadella’s world view, data generated by, living on, and enhanced by Microsoft’s software is the … Continue reading
Profusion of greenhouse flowers – tended by mechanized intelligence
Volante Farms of Needham, Massachusetts has a state-of-the-art energy efficient greenhouse. The ventilation, light level and watering are all controlled by computer algorithms. The computer monitors weather conditions inside and outside, including sunlight, temperature, wind, and humidity and then adjusts how … Continue reading
Pfizer’s real strategy is (mostly) tax-minimization
Many observers were initially left scratching their heads over Pfizer’s pursuit of AstraZeneca, a company that has had major pipeline troubles of its own. As more information has come out, Pfizer’s strategy is beginning to make sense. They aren’t pursuing an old-style mega … Continue reading
Posted in Pharmaceutical Industry
Tagged AstraZeneca, merger, Pfizer, Pharma, tax-avoidance
1 Comment
Undeterred, Pfizer continues its mega merger strategy
Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.
A new tool for measuring National economic output
Starting April 25, the Bureau of Economic Analysis will begin reporting quarterly measurements of gross output. Gross output represents, roughly speaking, the total value of sales by producing enterprises (their turnover) in an accounting period (e.g. a quarter or a year), before subtracting the … Continue reading
Pharma megamergers — against the spirit of the times?
Here’s more on the Novartis-GSK-Lilly three way deal announced Tuesday. As WSJ journalist Helen Thomas writes, the megamerger chill of dread felt when rumors of Pfizer’s stalking of AZ came to light last weekend may well be exorcized by this … Continue reading
Posted in Fixing Big Pharma Research, Pharmaceutical Industry
Tagged Eli Lilly, GSK, M&A, megamergers, Novartis, Pfizer, Pharmaceutical industry
1 Comment
MechanizedIntelligence 